408 related articles for article (PubMed ID: 12458153)
1. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.
Hassett DJ; Cuppoletti J; Trapnell B; Lymar SV; Rowe JJ; Yoon SS; Hilliard GM; Parvatiyar K; Kamani MC; Wozniak DJ; Hwang SH; McDermott TR; Ochsner UA
Adv Drug Deliv Rev; 2002 Dec; 54(11):1425-43. PubMed ID: 12458153
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.
Yoon SS; Hennigan RF; Hilliard GM; Ochsner UA; Parvatiyar K; Kamani MC; Allen HL; DeKievit TR; Gardner PR; Schwab U; Rowe JJ; Iglewski BH; McDermott TR; Mason RP; Wozniak DJ; Hancock RE; Parsek MR; Noah TL; Boucher RC; Hassett DJ
Dev Cell; 2002 Oct; 3(4):593-603. PubMed ID: 12408810
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
4. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung.
Mathee K; Ciofu O; Sternberg C; Lindum PW; Campbell JIA; Jensen P; Johnsen AH; Givskov M; Ohman DE; Søren M; Høiby N; Kharazmi A
Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1349-1357. PubMed ID: 10411261
[TBL] [Abstract][Full Text] [Related]
5. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections.
Kobayashi H
Treat Respir Med; 2005; 4(4):241-53. PubMed ID: 16086598
[TBL] [Abstract][Full Text] [Related]
6. Anaerobic Pseudomonas aeruginosa and other obligately anaerobic bacterial biofilms growing in the thick airway mucus of chronically infected cystic fibrosis patients: an emerging paradigm or "Old Hat"?
Su S; Hassett DJ
Expert Opin Ther Targets; 2012 Sep; 16(9):859-73. PubMed ID: 22793158
[TBL] [Abstract][Full Text] [Related]
7. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
[TBL] [Abstract][Full Text] [Related]
8. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
[TBL] [Abstract][Full Text] [Related]
9. Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients.
Lee B; Schjerling CK; Kirkby N; Hoffmann N; Borup R; Molin S; Høiby N; Ciofu O
APMIS; 2011 Apr; 119(4-5):263-74. PubMed ID: 21492226
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
Li Y; Huang J; Li L; Liu L
Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
[TBL] [Abstract][Full Text] [Related]
11. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.
Yoon SS; Coakley R; Lau GW; Lymar SV; Gaston B; Karabulut AC; Hennigan RF; Hwang SH; Buettner G; Schurr MJ; Mortensen JE; Burns JL; Speert D; Boucher RC; Hassett DJ
J Clin Invest; 2006 Feb; 116(2):436-46. PubMed ID: 16440061
[TBL] [Abstract][Full Text] [Related]
12. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts.
Rau MH; Hansen SK; Johansen HK; Thomsen LE; Workman CT; Nielsen KF; Jelsbak L; Høiby N; Yang L; Molin S
Environ Microbiol; 2010 Jun; 12(6):1643-58. PubMed ID: 20406284
[TBL] [Abstract][Full Text] [Related]
13. Chronic Pseudomonas aeruginosa infection in cystic fibrosis airway disease: metabolic changes that unravel novel drug targets.
Yoon SS; Hassett DJ
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):611-23. PubMed ID: 15482224
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
15. Understanding bacterial biofilms in patients with cystic fibrosis: current and innovative approaches to potential therapies.
Høiby N
J Cyst Fibros; 2002 Dec; 1(4):249-54. PubMed ID: 15463822
[TBL] [Abstract][Full Text] [Related]
16. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
[TBL] [Abstract][Full Text] [Related]
17. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function.
Hentzer M; Teitzel GM; Balzer GJ; Heydorn A; Molin S; Givskov M; Parsek MR
J Bacteriol; 2001 Sep; 183(18):5395-401. PubMed ID: 11514525
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
19. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung.
Schobert M; Jahn D
Int J Med Microbiol; 2010 Dec; 300(8):549-56. PubMed ID: 20951638
[TBL] [Abstract][Full Text] [Related]
20. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
Waite RD; Qureshi MR; Whiley RA
PLoS One; 2017; 12(3):e0173741. PubMed ID: 28301571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
